What's new

Annex 10 - 2024 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Annex 10 - 2024 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Jun 10, 2025 - 13:45
 0
Annex 10 - 2024 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication
Read More

Tags:

Previous Article

Annexes - 2024 annual report of the European Medicines Agency

Next Article

2024 annual report of the European Medicines Agency

Related Posts

Perfusion solutions

Perfusion solutions

Jun 12, 2025  0

Start of procedure - extension of marketing authorisati...

May 27, 2025  0

Human medicines European public assessment report (EPAR): Tecartus, brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0